Cambridge biotech behind first pig-to-human kidney transplant gets $191M
By Hannah Green The Cambridge company behind the technology that enabled the first-ever pig-to-human kidney transplant earlier this year has raised a mega-round of funding. The biotech eGenesis said on Wednesday that it has closed a $191 million Series D financing led by Lux Capital. Existing investors including Arch Ventures and Leaps by Bayer, as well new investors, also […]